↓ Skip to main content

Early termination of ISRCTN45828668, a phase 1/2 prospective, randomized study of Sulfasalazine for the treatment of progressing malignant gliomas in adults

Overview of attention for article published in BMC Cancer, October 2009
Altmetric Badge

Mentioned by

patent
1 patent

Citations

dimensions_citation
145 Dimensions

Readers on

mendeley
118 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Early termination of ISRCTN45828668, a phase 1/2 prospective, randomized study of Sulfasalazine for the treatment of progressing malignant gliomas in adults
Published in
BMC Cancer, October 2009
DOI 10.1186/1471-2407-9-372
Pubmed ID
Authors

Pierre A Robe, Didier H Martin, Minh T Nguyen-Khac, Maria Artesi, Manuel Deprez, Adelin Albert, Sophie Vanbelle, Stephane Califice, Markus Bredel, Vincent Bours

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 118 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
France 1 <1%
Belgium 1 <1%
Brazil 1 <1%
Unknown 115 97%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 18 15%
Researcher 18 15%
Student > Master 16 14%
Student > Bachelor 13 11%
Professor > Associate Professor 5 4%
Other 16 14%
Unknown 32 27%
Readers by discipline Count As %
Medicine and Dentistry 25 21%
Biochemistry, Genetics and Molecular Biology 20 17%
Agricultural and Biological Sciences 14 12%
Pharmacology, Toxicology and Pharmaceutical Science 6 5%
Neuroscience 5 4%
Other 10 8%
Unknown 38 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 May 2017.
All research outputs
#7,550,598
of 23,035,022 outputs
Outputs from BMC Cancer
#2,097
of 8,365 outputs
Outputs of similar age
#33,854
of 94,320 outputs
Outputs of similar age from BMC Cancer
#11
of 28 outputs
Altmetric has tracked 23,035,022 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,365 research outputs from this source. They receive a mean Attention Score of 4.3. This one has gotten more attention than average, scoring higher than 68% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 94,320 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 20th percentile – i.e., 20% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 28 others from the same source and published within six weeks on either side of this one. This one is in the 21st percentile – i.e., 21% of its contemporaries scored the same or lower than it.